Bill > HR7062

Introduced Session

To amend title XVIII of the Social Security Act to eliminate cost-sharing with respect to coverage of insulin as a covered part D drug and associated medical supplies and to provide mail order access to insulin and such supplies under the Medicare program during the COVID-19 emergency period. This bill eliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows beneficiaries to receive their insulin and supplies via mail order during the emergency period.

AI Summary

Committee Categories

Maxine Waters (D)*,  Nanette Barragán (D),  Karen Bass (D),  Joyce Beatty (D),  Sanford Bishop (D),  Anthony Brown (D),  André Carson (D),  Judy Chu (D),  Steve Cohen (D),  Peter DeFazio (D),  Marcia Fudge (D),  Sylvia Garcia (D),  Chuy García (D),  Raúl Grijalva (D),  Alcee Hastings (D),  Jahana Hayes (D),  Sheila Jackson-Lee (D),  Eddie Johnson (D),  Dan Kildee (D),  John Larson (D),  Barbara Lee (D),  Daniel Lipinski (D),  Gregory Meeks (D),  Grace Meng (D),  Joe Morelle (D),  Grace Napolitano (D),  Joe Neguse (D),  Eleanor Holmes Norton (D),  Donald Payne (D),  Mark Pocan (D),  Lucille Roybal-Allard (D),  Bobby Rush (D),  Mary Gay Scanlon (D),  David Scott (D),  José Serrano (D),  Darren Soto (D),  Tom Suozzi (D),  Bennie Thompson (D),  Rashida Tlaib (D),  Lauren Underwood (D),  Nydia Velázquez (D),  Peter Welch (D),  Susan Wild (D),  Frederica Wilson (D), 

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (on 05/28/2020)

Official Document